Table 1.
Senescence-associated secretory phenotype (SASP) factors with potential effect on platelets aggregation and the fibrinolytic system.
| SASP component | Function |
|---|---|
| Interleukin-6 | Upregulates the production of hepatic thrombopoetin, elevating the number of platelets number (24) |
| IL-11 | Contributes to megakaryopoiesis and thus indirectly to thrombopoiesis (51, 128) |
| PAI-1 | Main inhibitor of tissue plasminogen activator and urokinase (24), regulates the dissolution of fibrin and also inhibits the degradation of the extracellular matrix by reducing plasmin generation (129) |
| MMP-2 | Released by tumor cells and activated platelets in vitro (130) |
| GM-CSF | Contributes to megakaryopoiesis and thus indirectly to thrombopoiesis (51) |
| Fibronectin | Involved in cell adhesion and migration processes, including embryogenesis, wound healing, blood coagulation, host defense, and metastasis (131) |
| THPO | Necessary for megakaryocyte proliferation and maturation, as well as for thrombopoiesis (132) |
| Granulocyte colony-stimulating factor (G-CSF) | Cancer cell releases high levels of G-CSF primed neutrophils to release NETs, activating platelets (133), and also contributes to megakaryopoiesis and thus indirectly to thrombopoiesis (51) |
| MMP1 | Activates protease-activated receptor-1 (PAR-1) by cleaving the receptor and promotes platelet aggregation through PAR-1 (134) |